135 related articles for article (PubMed ID: 16536802)
1. Psoriatic skin expresses the transcription factor Gli1: possible contribution of decreased neurofibromin expression.
Endo H; Momota Y; Oikawa A; Shinkai H
Br J Dermatol; 2006 Apr; 154(4):619-23. PubMed ID: 16536802
[TBL] [Abstract][Full Text] [Related]
2. Lack of evidence for activation of the hedgehog pathway in psoriasis.
Gudjonsson JE; Aphale A; Grachtchouk M; Ding J; Nair RP; Wang T; Voorhees JJ; Dlugosz AA; Elder JT
J Invest Dermatol; 2009 Mar; 129(3):635-40. PubMed ID: 18754037
[TBL] [Abstract][Full Text] [Related]
3. Plexiform neurofibromas express the transcription factor Gli1.
Endo H; Oikawa A; Utani A; Shinkai H
Dermatology; 2004; 209(4):284-7. PubMed ID: 15539889
[TBL] [Abstract][Full Text] [Related]
4. Decreased expression of neurofibromin contributes to epithelial-mesenchymal transition in neurofibromatosis type 1.
Arima Y; Hayashi H; Kamata K; Goto TM; Sasaki M; Kuramochi A; Saya H
Exp Dermatol; 2010 Aug; 19(8):e136-41. PubMed ID: 20002172
[TBL] [Abstract][Full Text] [Related]
5. Neurofibromatosis type 1 tumour suppressor gene expression is deficient in psoriatic skin in vivo and in vitro: a potential link to increased Ras activity.
Karvonen SL; Koivunen J; Nissinen M; Ylä-Outinen H; Björkstrand AS; Peltonen J
Br J Dermatol; 2004 Feb; 150(2):211-9. PubMed ID: 14996090
[TBL] [Abstract][Full Text] [Related]
6. Lesional psoriatic epidermis displays reduced neurofibromin immunoreactivity.
Peltonen J; Karvonen SL; Ylä-Outinen H; Hirvonen O; Karvonen J
J Invest Dermatol; 1995 Nov; 105(5):664-7. PubMed ID: 7594640
[TBL] [Abstract][Full Text] [Related]
7. Human GLI2 and GLI1 are part of a positive feedback mechanism in Basal Cell Carcinoma.
Regl G; Neill GW; Eichberger T; Kasper M; Ikram MS; Koller J; Hintner H; Quinn AG; Frischauf AM; Aberger F
Oncogene; 2002 Aug; 21(36):5529-39. PubMed ID: 12165851
[TBL] [Abstract][Full Text] [Related]
8. The role of proto-oncogene GLI1 in pituitary adenoma formation and cell survival regulation.
Lampichler K; Ferrer P; Vila G; Lutz MI; Wolf F; Knosp E; Wagner L; Luger A; Baumgartner-Parzer S
Endocr Relat Cancer; 2015 Oct; 22(5):793-803. PubMed ID: 26219678
[TBL] [Abstract][Full Text] [Related]
9. Psoriatic lesional skin exhibits an aberrant expression pattern of interferon regulatory factor-2 (IRF-2).
van der Fits L; van der Wel LI; Laman JD; Prens EP; Verschuren MC
J Pathol; 2003 Jan; 199(1):107-14. PubMed ID: 12474233
[TBL] [Abstract][Full Text] [Related]
10. STAT1 expression and activation is increased in lesional psoriatic skin.
Hald A; Andrés RM; Salskov-Iversen ML; Kjellerup RB; Iversen L; Johansen C
Br J Dermatol; 2013 Feb; 168(2):302-10. PubMed ID: 23013371
[TBL] [Abstract][Full Text] [Related]
11. Suppression of Hedgehog signalling promotes pro-tumourigenic integrin expression and function.
Moutasim KA; Mellows T; Mellone M; Lopez MA; Tod J; Kiely PC; Sapienza K; Greco A; Neill GW; Violette S; Weinreb PH; Marshall JF; Ottensmeier CH; Sayan AE; Jenei V; Thomas GJ
J Pathol; 2014 Jun; 233(2):196-208. PubMed ID: 24573955
[TBL] [Abstract][Full Text] [Related]
12. Downregulation of SMAD2, 4 and 6 mRNA and TGFbeta receptor I mRNA in lesional and non-lesional psoriatic skin.
Yu H; Mrowietz U; Seifert O
Acta Derm Venereol; 2009; 89(4):351-6. PubMed ID: 19688145
[TBL] [Abstract][Full Text] [Related]
13. In psoriasis lesional skin the type I interferon signaling pathway is activated, whereas interferon-alpha sensitivity is unaltered.
van der Fits L; van der Wel LI; Laman JD; Prens EP; Verschuren MC
J Invest Dermatol; 2004 Jan; 122(1):51-60. PubMed ID: 14962089
[TBL] [Abstract][Full Text] [Related]
14. Gli1, downregulated in colorectal cancers, inhibits proliferation of colon cancer cells involving Wnt signalling activation.
Akiyoshi T; Nakamura M; Koga K; Nakashima H; Yao T; Tsuneyoshi M; Tanaka M; Katano M
Gut; 2006 Jul; 55(7):991-9. PubMed ID: 16299030
[TBL] [Abstract][Full Text] [Related]
15. Gli1 protein is expressed in basal cell carcinomas, outer root sheath keratinocytes and a subpopulation of mesenchymal cells in normal human skin.
Ghali L; Wong ST; Green J; Tidman N; Quinn AG
J Invest Dermatol; 1999 Oct; 113(4):595-9. PubMed ID: 10504446
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of tumour necrosis factor-alpha-converting enzyme in psoriasis.
Kawaguchi M; Mitsuhashi Y; Kondo S
Br J Dermatol; 2005 May; 152(5):915-9. PubMed ID: 15888146
[TBL] [Abstract][Full Text] [Related]
17. Downregulation of TGFbeta isoforms and their receptors contributes to keratinocyte hyperproliferation in psoriasis vulgaris.
Doi H; Shibata MA; Kiyokane K; Otsuki Y
J Dermatol Sci; 2003 Oct; 33(1):7-16. PubMed ID: 14527734
[TBL] [Abstract][Full Text] [Related]
18. The expression of dual-specificity phosphatase 1 mRNA is downregulated in lesional psoriatic skin.
Kjellerup RB; Johansen C; Kragballe K; Iversen L
Br J Dermatol; 2013 Feb; 168(2):339-45. PubMed ID: 22924482
[TBL] [Abstract][Full Text] [Related]
19. Abnormal regulation of fibronectin production by fibroblasts in psoriasis.
Gubán B; Vas K; Balog Z; Manczinger M; Bebes A; Groma G; Széll M; Kemény L; Bata-Csörgő Z
Br J Dermatol; 2016 Mar; 174(3):533-41. PubMed ID: 26471375
[TBL] [Abstract][Full Text] [Related]
20. The Hedgehog pathway is a possible therapeutic target for patients with estrogen receptor-negative breast cancer.
Kameda C; Tanaka H; Yamasaki A; Nakamura M; Koga K; Sato N; Kubo M; Kuroki S; Tanaka M; Katano M
Anticancer Res; 2009 Mar; 29(3):871-9. PubMed ID: 19414322
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
